Cargando…

Transforming growth factor-beta-1 is a serum biomarker of radiation-induced pneumonitis in esophageal cancer patients treated with thoracic radiotherapy: preliminary results of a prospective study

OBJECTIVE: To examine the relationship between cytokine levels of transforming growth factor-beta-1 (TGF-β1), interleukin-1 beta (IL-1β), and angiotensin-converting enzyme (ACE) in the plasma of esophageal carcinoma patients and radiation-induced pneumonitis (RP). MATERIALS AND METHODS: Sixty-three...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jingxia, Mu, Shuangfeng, Mu, Lixiang, Zhang, Xiaohui, Pang, Ranran, Gao, Shegan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446015/ https://www.ncbi.nlm.nih.gov/pubmed/26056477 http://dx.doi.org/10.2147/OTT.S79433

Ejemplares similares

A novel nomogram containing acute radiation esophagitis predicting radiation pneumonitis in thoracic cancer receiving radiotherapy
por: Tang, Wenjie, et al.
Publicado: (2021)

Variations of circulating endothelial progenitor cells and transforming growth factor-beta-1 (TGF-β1) during thoracic radiotherapy are predictive for radiation pneumonitis
por: Liu, Yunfang, et al.
Publicado: (2013)

Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy
por: Zhuang, Hongqing, et al.
Publicado: (2014)

Association of volumetric-modulated arc therapy with radiation pneumonitis in thoracic esophageal cancer
por: Inoo, Hiroyuki, et al.
Publicado: (2022)

Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer
por: Ding, Xiao, et al.
Publicado: (2011)

Genetic Variants in MTHFR Gene Predict ≥ 2 Radiation Pneumonitis in Esophageal Squamous Cell Carcinoma Patients Treated with Thoracic Radiotherapy
por: Zhang, Yang, et al.
Publicado: (2017)

Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer
por: Lu, Xiaotong, et al.
Publicado: (2022)

Analysis of the risk factors of radiation pneumonitis in patients after radiotherapy for esophageal squamous cell carcinoma
por: Sun, Lu, et al.
Publicado: (2023)

Diabetes mellitus is a predictive factor for radiation pneumonitis after thoracic radiotherapy in patients with lung cancer
por: Kong, Moonkyoo, et al.
Publicado: (2019)

Measurement of exhaled nitric oxide and serum surfactant protein D levels for monitoring radiation pneumonitis following thoracic radiotherapy
por: Yamazaki, Hideya, et al.
Publicado: (2017)

Radiation Pneumonitis after Radiotherapy of Neck Lymphoma
por: Wei, Min, et al.
Publicado: (2014)

Overlap time is an independent risk factor of radiation pneumonitis for patients treated with simultaneous EGFR-TKI and thoracic radiotherapy
por: Jia, Wenxiao, et al.
Publicado: (2021)

Radiation Pneumonitis after Intensity-Modulated Radiotherapy for Esophageal Cancer: Institutional Data and a Systematic Review
por: Tonison, J. J., et al.
Publicado: (2019)

Establishment and Verification of a Prediction Model for Symptomatic Radiation Pneumonitis in Patients with Esophageal Cancer Receiving Radiotherapy
por: Yang, Liu-Ting, et al.
Publicado: (2021)

Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and Osimertinib
por: Smith, Clayton P., et al.
Publicado: (2023)

Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs
por: Mu, Fengchun, et al.
Publicado: (2023)

A simple-to-use nomogram for predicting the risk of radiation pneumonitis in patients with thoracic segment esophageal squamous cell carcinoma
por: Qiu, Ting, et al.
Publicado: (2022)

Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study
por: Banla, Leou Ismael, et al.
Publicado: (2023)

The role of procalcitonin in differential diagnosis between acute radiation pneumonitis and bacterial pneumonia in lung cancer patients receiving thoracic radiotherapy
por: Wang, Zhiwu, et al.
Publicado: (2020)

Are there overlapping clinical features between thoracic radiotherapy side effects and covid-19 pneumonia? Radiation pneumonitis outside the radiation ports: Three case reports
por: Lazzari, Grazia, et al.
Publicado: (2020)

Radiation Pneumonitis in Thoracic Cancer Patients: Multi-Center Voxel-Based Analysis
por: Palma, Giuseppe, et al.
Publicado: (2021)

Biological dosiomic features for the prediction of radiation pneumonitis in esophageal cancer patients
por: Puttanawarut, Chanon, et al.
Publicado: (2021)

Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer
por: Castillo, Richard, et al.
Publicado: (2014)

Effects of diabetes on the development of radiation pneumonitis
por: Dong, Guangtong, et al.
Publicado: (2021)

Dosiomics and radiomics to predict pneumonitis after thoracic stereotactic body radiotherapy and immune checkpoint inhibition
por: Kraus, Kim Melanie, et al.
Publicado: (2023)

The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation
por: Ren, Chengbo, et al.
Publicado: (2018)

Relationship between radiation pneumonitis and organizing pneumonia after radiotherapy for breast cancer
por: Oie, Yumi, et al.
Publicado: (2013)

Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy
por: Ryckman, Jeffrey M., et al.
Publicado: (2020)

Nivolumab‐induced radiation recall pneumonitis in non‐small‐cell lung cancer patients with thoracic radiation therapy
por: Noda‐Narita, Shoko, et al.
Publicado: (2022)

Radiomic and Dosiomic Features for the Prediction of Radiation Pneumonitis Across Esophageal Cancer and Lung Cancer
por: Puttanawarut, Chanon, et al.
Publicado: (2022)

Genetic variants of SP‐D confer susceptibility to radiation pneumonitis in lung cancer patients undergoing thoracic radiation therapy
por: Xu, Li, et al.
Publicado: (2019)

Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy
por: Li, Fangjuan, et al.
Publicado: (2021)

Decreased risk of radiation pneumonitis with concurrent use of renin-angiotensin system inhibitors in thoracic radiation therapy of lung cancer
por: Zheng, Yawen, et al.
Publicado: (2023)

Effects of Proton Pump Inhibitors on Lung Cancer Precise Radiotherapy-Induced Radiation Pneumonitis
por: Su, QiaoLi, et al.
Publicado: (2014)

High incidence of radiation pneumonitis in lung cancer patients with chronic silicosis treated with radiotherapy
por: Shen, Tianle, et al.
Publicado: (2019)

Correction to: Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy
por: Ryckman, Jeffrey M., et al.
Publicado: (2021)

Predicting the Risk of Radiation Pneumonitis and Pulmonary Function Changes after Breast Cancer Radiotherapy
por: Mehnati, Parinaz, et al.
Publicado: (2021)

Symptomatic Radiation Pneumonitis in NSCLC Patients Receiving EGFR-TKIs and Concurrent Once-daily Thoracic Radiotherapy: Predicting the Value of Clinical and Dose-volume Histogram Parameters
por: YANG, Xuexi, et al.
Publicado: (2022)

A Novel Nomogram Model Based on Cone-Beam CT Radiomics Analysis Technology for Predicting Radiation Pneumonitis in Esophageal Cancer Patients Undergoing Radiotherapy
por: Du, Feng, et al.
Publicado: (2020)

Radiation pneumonitis complicated by Pneumocystis carinii in patients with thoracic neoplasia: a clinical analysis of 7 cases
por: Fu, Zhixue, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4psjrhsd3vbb2js5iukjtvtekt